Yazar "Akgül, Fahri" için listeleme
-
The optimal treatment approaches and prognostic factors in elderly patients with advanced stage biliary tract tumors
Göktaş Aydın, Sabin; Çakan Demirel, Burçin; Bilici, Ahmet; Yılmaz, Cansu; Topçu, Atakan; Aykan, Musa Barış; Kahraman, Seda; Atcı, Muhammed Mustafa; Akbıyık, Ilgın; Akgül, Fahri; Ölmez, Ömer Fatih; Aydın, Ahmet (Ankara Hematology Oncology Association, 2023)Introduction: There is a lack of evidence of the outcomes in elderly patients advanced stage biliary tract cancer due to the patients aged over 65 years are less than 25% in many prospective trials. We designed a retrospective ... -
Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study
Göktaş Aydın, Sabin; Kavak, Engin Eren; Topçu, Atakan; Bayramgil, Ayberk; Akgül, Fahri; Kahraman, Seda; Aykan, Musa Barış; Altıntaş, Yunus Emre; Helvacı, Kaan; Ürün, Yüksel; Bilici, Ahmet; Şeker, Mesut (Association of Basic Medical Sciences of FBIH, 2023)Regorafenib, an oral multikinase inhibitor, has improved survival in metastatic colorectal cancer (mCRC) patients who have progressed on standard therapies. Our study aimed to evaluate prognostic factors influencing ... -
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: A retrospective Turkish oncology group (TOG) study
Bilici, Ahmet; Koca, Sinan; Karaağaç, Mustafa; Aydın Göktaş, Sabin; Eraslan, Emrah; Kaplan, Muhammed Ali; Ocak, Birol; Göksu, Sema Sezgin; Paydaş, Semra; Akgül, Fahri; Derin, Sümeyye; Ergün, Yakup (Springer, 2023)Aim: Description of patient characteristics, effectiveness and safety in Turkish patients treated with pazopanib for metastatic soft tissue sarcoma (STS). Patients and methods: This multicenter study is based on retrospective ...